The emergence of new psychoactive substances has created challenges for toxicologists, healthcare professionals, and public health researchers. Among these compounds, ADB-BUTINACA is recognized as a synthetic cannabinoid that has attracted attention because of its activity at cannabinoid receptors and reports of adverse effects. Understanding its classification, possible biological effects, and associated health concerns can help explain why emerging synthetic cannabinoids require careful scientific evaluation and responsible public health communication. Understanding Its Classification ADB-BUTINACA belongs to the broader category of synthetic cannabinoids. These are laboratory-produced substances that are designed to interact with cannabinoid receptors in the body's endocannabinoid system. Although they may...